Tailor Bio
Focus: Tailor Bio is a UK-based oncology biotech company focused on cancer treatments, operating from Cambridge. The company is actively hiring across 39 open roles, suggesting early-stage expansion.
Profile data last refreshed 34m ago · AI intelligence enriched 1w ago
Open Jobs
46+59 this month
Hot — 60 jobs added in 30d
Net +59 (60 new, 1 removed). Aggressive expansion phase.
Should You Work at Tailor Bio?
AI assessmentTailor Bio presents a high-risk, high-reward early-stage opportunity suitable for biotech specialists willing to tolerate pre-clinical opacity in exchange for ground-floor equity and tech-forward drug development exposure.
Why Work Here
- Early-stage oncology play with focused therapeutic area positioning in a high-value cancer market
- Actively hiring across 39 roles with perfect H1B approval rate (2/2 approvals, 0 denials in 2023), signaling immigration-friendly hiring infrastructure
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tailor Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.